Business Context and Reporting Period
Company: TEAM, INC. (NYSE: TISI)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Quarter and six months ended June 30, 2024
Business Overview: A global provider of specialty industrial services operating in two segments: Inspection and Heat Treating (IHT) and Mechanical Services (MS). Services include non-destructive testing, heat treating, maintenance, and repair for energy, manufacturing, midstream, infrastructure, and aerospace sectors.
Key Financial Metrics
| Metric (in thousands) | Q2 2024 | Q2 2023 | YTD 2024 | YTD 2023 |
|---|---|---|---|---|
| Revenues | $228,618 | $239,492 | $428,218 | $441,769 |
| Operating Income | $11,159 | $4,596 | $4,773 | $(3,150) |
| Net Loss | $(2,763) | $(15,753) | $(19,958) | $(40,464) |
| Diluted EPS | $(0.63) | $(3.61) | $(4.52) | $(9.30) |
| Adjusted EBITDA | $21,813 | $17,445 | $28,320 | $21,652 |
| Cash and Equivalents | $22,461 | $30,437 | $22,461 | $30,437 |
| Total Debt (incl. leases) | $320,107 | $311,426 | $320,107 | $311,426 |
| Free Cash Flow | $(9,095) | $(8,235) | $(10,225) | $(28,690) |
Note: Free Cash Flow is defined by the company as net cash used in operating activities minus capital expenditures.
Material Changes vs. Prior Period
- Revenue Decline: Total revenue decreased 4.5% in Q2 and 3.1% YTD compared to the prior year. The decline was driven by lower activity in Canada and international regions for both IHT and MS segments, partially offset by increased aerospace revenue in IHT.
- Operating Profitability Improvement: Operating income improved significantly to $11.2 million in Q2 (from $4.6 million) and $4.8 million YTD (from a loss of $3.2 million). This was primarily due to cost reduction actions and improved margins in the U.S. IHT segment.
- Reduced Net Loss: Net loss narrowed by 82.5% in Q2 and 50.7% YTD. The reduction is largely attributed to a decrease in interest expense (due to the absence of accelerated amortization of debt costs seen in the prior year) and improved operating income.
- Cash Flow: Net cash used in operating activities improved by 81% YTD to $4.5 million, driven by a reduction in non-cash debt amortization charges and lower net loss, despite negative working capital changes.
Guidance, Outlook, Risks, and Contingencies
- NYSE Listing Compliance: The company received notice on March 14, 2024, of non-compliance with NYSE listing standards due to market capitalization and shareholders' equity falling below $50 million. A compliance plan was accepted by the NYSE on April 29, 2024, granting a 12-month cure period. Failure to regain compliance could result in delisting, which may trigger cross-defaults on debt agreements.
- Liquidity Position: As of June 30, 2024, the company reported total liquidity of approximately $32.3 million, comprising $19.5 million in cash (excluding restricted cash) and $12.8 million in undrawn borrowing capacity. Management believes this is sufficient to fund operations and service debt for the next 12 months.
- Debt Structure: Total debt obligations are approximately $320 million. The company has significant interest rate exposure with variable rates on its ABL facility and term loans. Paid-in-kind (PIK) interest on the Uptiered Loan adds to the principal balance.
- Legal Contingencies:
- Kelli Most Litigation: A $222 million wrongful death verdict was vacated by the Texas First Court of Appeals in May 2024. The plaintiff may seek review in the Texas Supreme Court. The company has accrued a liability of $39.0 million, which is largely covered by insurance.
- Government Subsidy Repayment: The company accrued $5.5 million for the repayment of pandemic-related government subsidies due to non-compliance findings.
- Risk Factors: Key risks include the ability to generate sufficient cash flow, access to capital markets, inflationary pressures on operating costs, and the outcome of ongoing litigation.
Investor Verification Checklist
- NYSE Compliance Plan: Verify the specific actions and milestones in the company's plan to restore market capitalization and equity above $50 million within the 12-month cure period.
- Debt Covenants: Review the financial covenants in the 2022 ABL Credit Agreement and A&R Term Loan Credit Agreement to assess the margin of safety given current leverage and liquidity levels.
- Legal Accruals: Confirm the status of the Kelli Most litigation appeal and the adequacy of the $39 million accrual versus potential insurance recoveries.
- Working Capital Trends: Monitor the increase in accounts receivable and the reduction in accrued liabilities, which contributed to negative cash flow from operations despite improved net income.
- Interest Rate Exposure: Assess the impact of rising interest rates on the variable-rate portions of the debt portfolio and the compounding effect of PIK interest.